Companion Animal Cardiac Drugs Market

Future Market Insights

Key Insight

The companion animal cardiac drugs market is projected to grow from USD 2.0 billion in 2025 to USD 4.4 billion by 2035, at a CAGR of 8.1%. Dogs will dominate with a 64.7% market share, while Pimobendane will lead the product outlook segment with a 41.2% share.

September 23, 2025

Anurag Sharma

250 Pages

Cite this Report

Companion Animal Cardiac Drugs Market

https://www.futuremarketinsights.com/reports/companion-animal-cardiac-drugs-market

License

Buy Now

Summary ToC Companies

Key Players

Bimeda Corporate
Boehringer Ingelheim
Boehringer Ingelheim International GmbH
Ceva
Dechra Pharmaceuticals PLC
Elanco
Merck KGaA
Vetoquinol S.A
Virbac
Zoetis Inc

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Companion Animal Cardiac Drugs Market

Key Players

Similar Industry Reports